Legend Biotech Corp balance sheet

At the end of fiscal 2025, Legend Biotech Corp had total assets of $1.73bn, total liabilities of $732m and shareholders' equity of $1.00bn. It held $902m in cash against $319m of debt: net cash of $583m.

Balance sheet

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Legend Biotech Corp: balance sheet, annual
Fiscal year	2018Dec 2018	2019Dec 2019	2020Dec 2020	2021Dec 2021	2022Dec 2022	2023Dec 2023	2024Dec 2024	2025Dec 2025
Cash and equivalents	210	83	456	689	786	1,278	287	902
Inventory	—	1	2	2	10	19	24	32
Total current assets	—	212	594	950	1,099	1,498	1,284	1,247
Total assets	—	293	722	1,119	1,331	1,849	1,670	1,734
Total current liabilities	—	94	116	229	298	216	278	636
Long-term debt	—	—	—	120	261	281	301	0
Total debt	0	—	0	120	261	281	301	319
Total liabilities	—	141	124	354	587	597	630	732
Shareholders' equity	253	151	598	766	744	1,251	1,041	1,002
Net debt (negative = net cash)	−210	−83	−456	−568	−525	−996	15	−583

Balances at each fiscal year end (quarter end in the quarterly view). Total debt is short- plus long-term borrowings, including lease debt where the company reports it within debt. Where assets do not equal liabilities plus shareholders' equity, the difference (non-controlling interests, redeemable preferred shares) is shown on its own line.

Compare with peers

Head to head: KNSA vs LEGN BBIO vs LEGN BCRX vs LEGN ACAD vs LEGN

More: Biotechnology stocks compared, Health Care sector, rankings of US companies

Figures from Legend Biotech Corp's SEC filings (10-K and 10-Q), retrieved November 1, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Legend Biotech Corp.